<?xml version="1.0" encoding="UTF-8"?>
<ref id="pone.0229239.ref021">
 <label>21</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>Ogawa</surname>
   <given-names>E</given-names>
  </name>, 
  <name>
   <surname>Furusyo</surname>
   <given-names>N</given-names>
  </name>, 
  <name>
   <surname>Nakamuta</surname>
   <given-names>M</given-names>
  </name>, 
  <name>
   <surname>Nomura</surname>
   <given-names>H</given-names>
  </name>, 
  <name>
   <surname>Satoh</surname>
   <given-names>T</given-names>
  </name>, 
  <name>
   <surname>Takahashi</surname>
   <given-names>K</given-names>
  </name>, 
  <etal>et al</etal>
  <article-title>Glecaprevir and Pibrentasvir for Japanese patients with chronic hepatitis C genotype 1 or 2 infection: Results from a multicenter, real-world cohort study</article-title>. 
  <source>Hepatol Res Off J Jpn Soc Hepatol</source>. 
  <year>2019</year>
  <month>3</month>
  <day>8</day>;
 </mixed-citation>
</ref>
